Statins are lipid-lowering agents or medications used in the treatment of high lipid levels. These are often referred to as high cholesterol found in the blood. The primary function of statins is to lower blood cholesterol and prevent atherosclerosis. According to studies, statins have reduced heart attacks and strokes by 25% to 35%. Statins recommended by health care practitioners work well for patients with balanced nutritious food and exercise.
MARKET DYNAMICS
The statins market is driving due to the rise in health care expenditure, technological advancements. However, increase in demand for effective treatment alternatives acts as a major restraint of the market. Social and economic factors also hamper the global statins market. Moreover, the increase in incidence of lifestyle diseases also boost the growth of the market for statins.
MARKET SCOPE
The "Statins Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of statins market with detailed market segmentation by product class, application and end user. The statins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in statins market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The statins market is segmented on the basis of product class, application and end user. Based on product class, the market is segmented as atorvastatin (Lipitor & others), fluvastatin (Lescol, Canef, and Vastin), lovastatin (Mevacor & others), pravastatin (Pravachol), rosuvastatin (Crestor), simvastatin (Zocor), and pitavastatin (Livalo). On the basis of application, the market is categorized as cardiovascular diseases (heart strokes & attacks), lifestyle diseases (obesity, diabetes, and inflammation), and others. On the basis of end user, the market is categorized as hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the statins market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The statins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting statins market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the statins market in these regions.
MARKET PLAYERS
The report covers key developments in the statins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from statins market are anticipated to have lucrative growth opportunities in the future with the rising demand for statins in the global market. Below mentioned is the list of few companies engaged in the statins market.
The report also includes the profiles of key players in statins market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Amgen
- AstraZeneca
- Aurbindo Pharma
- Biocon
- Concord Biotech
- GlaxoSmithKline plc,
- Merck & Co., Inc.
- Pfizer, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.